The Research and Development Team at OncoNano Medicine focuses on advancing the company's innovative pH-activated compounds by conducting cutting-edge research and optimizing therapeutic and imaging agents. This team collaborates closely to explore pH variability in disease, driving the development of targeted solutions that enhance identification and treatment of diseased tissues, ultimately contributing to the company's mission of transforming cancer care.
View all